Cytosorbents Corp (CTSO)

Nov 26, 2024

CytoSorbents to Present at Piper Sandler's 36th Annual Healthcare Conference | CTSO Stock News - StockTitan

Nov 26, 2024

Nov 26, 2024

Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - MarketBeat

Nov 26, 2024

Nov 20, 2024

Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World

Nov 20, 2024

Nov 15, 2024

Granahan Investment Management Reduces Stake in CytoSorbents Cor - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

FY2024 EPS Estimates for Cytosorbents Decreased by Analyst - Defense World

Nov 15, 2024

Nov 14, 2024

FY2024 EPS Estimate for Cytosorbents Decreased by Analyst - MarketBeat

Nov 14, 2024

Nov 11, 2024

Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 11, 2024

CytoSorbents And Converge Biotech Announce Strategic - GlobeNewswire

Nov 11, 2024

Nov 11, 2024

CytoSorbents Expands Into India Through Strategic Converge Biotech Partnership | CTSO Stock News - StockTitan

Nov 11, 2024

Nov 10, 2024

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat

Nov 10, 2024

Nov 08, 2024

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ... - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024

Nov 08, 2024

CytoSorbents Corporation’s Q3 2024 Financial Highlights - TipRanks

Nov 08, 2024

Nov 07, 2024

CytoSorbents: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024

Nov 07, 2024

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results - StockTitan

Nov 07, 2024

Nov 06, 2024

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ah - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

CytoSorbents (STU:HQE1) 3-Year EPS without NRI Growth Rate : -38.10% (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

CytoSorbents (STU:HQE1) 3-Year EBITDA Growth Rate : -37.70% (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

CytoSorbents (STU:HQE1) 3-Year FCF Growth Rate : -39.10% (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

CytoSorbents (STU:HQE1) 5-Day RSI : 14.64 (As of Nov. 05, 2024) - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

CytoSorbents (STU:HQE1) Operating Income : €-23.16 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification - StockTitan

Nov 04, 2024

Nov 02, 2024

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 02, 2024

Oct 31, 2024

Cytosorbents (CTSO) to Release Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 29, 2024

Cytosorbents (NASDAQ:CTSO) and Caliber Imaging & Diagnostics (OTCMKTS:LCDX) Critical Comparison - Defense World

Oct 29, 2024

Oct 22, 2024

Analyst Scoreboard: 5 Ratings For CytoSorbents - Benzinga

Oct 22, 2024

Oct 22, 2024

Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts - Benzinga

Oct 22, 2024

Oct 22, 2024

FDA begins review of CytoSorbents' bleeding reduction device - Investing.com

Oct 22, 2024

Oct 22, 2024

FDA begins review of CytoSorbents' bleeding reduction device By Investing.com - Investing.com UK

Oct 22, 2024

Oct 22, 2024

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review - StockTitan

Oct 22, 2024

Oct 22, 2024

CytoSorbents (STU:HQE1) Forward Dividend Yield % : 0.00% (As of Nov. 05, 2024) - GuruFocus.com

Oct 22, 2024

Oct 17, 2024

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results - StockTitan

Oct 17, 2024

Oct 17, 2024

Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - MarketBeat

Oct 17, 2024

Oct 16, 2024

Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 5.7% in September - MarketBeat

Oct 16, 2024

Oct 09, 2024

CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance

Oct 09, 2024

Oct 02, 2024

CytoSorbents maintains Buy rating from B.Riley with no change in target price - Investing.com

Oct 02, 2024

Oct 01, 2024

Cytosorbents announces $20 million "at the market" equity offering - Investing.com

Oct 01, 2024

Oct 01, 2024

Cytosorbents Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits - Quantisnow

Oct 01, 2024

Oct 01, 2024

DrugSorb-ATR seeks FDA priority review for surgery bleeding - Investing.com

Oct 01, 2024

Oct 01, 2024

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - The Manila Times

Oct 01, 2024

Oct 01, 2024

Cytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.com - MarketBeat

Oct 01, 2024

Sep 30, 2024

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago - Yahoo Finance

Sep 30, 2024

Sep 23, 2024

Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Sep 23, 2024